IMCR
Income statement / Annual
Last year (2023), Immunocore Holdings plc's total revenue was $249.43 M,
an increase of 73.53% from the previous year.
In 2023, Immunocore Holdings plc's net income was -$55.29 M.
See Immunocore Holdings plc’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$249.43 M
|
$143.74 M
|
$26.52 M
|
$30.11 M
|
$25.67 M
|
$23.65 M
|
| Cost of Revenue |
$1.04 M |
$454,000.00 |
$73.23 M |
$74.81 M |
$99.99 M |
$0.00 |
| Gross Profit |
$248.39 M |
$143.28 M |
-$46.71 M |
-$44.70 M |
-$74.32 M |
$23.65 M |
| Gross Profit Ratio |
1 |
1 |
-1.76 |
-1.48 |
-2.9 |
1 |
| Research and Development
Expenses |
$163.55 M
|
$89.17 M
|
$73.23 M
|
$74.81 M
|
$99.99 M
|
$83.58 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$88.40 M
|
$45.74 M
|
$44.18 M
|
$34.16 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$99.99 M
|
$83.58 M
|
| Selling, General &
Administrative Expenses |
$144.50 M
|
$93.72 M
|
$88.40 M
|
$45.74 M
|
$44.18 M
|
$34.16 M
|
| Other Expenses |
-$897,000.00 |
-$3,000.00 |
$57,000.00 |
-$1.15 M |
$185,000.00 |
$5.60 M |
| Operating Expenses |
$308.04 M |
$182.89 M |
$161.68 M |
$119.40 M |
$144.17 M |
$117.73 M |
| Cost And Expenses |
$309.08 M |
$183.34 M |
$161.68 M |
$119.40 M |
$144.17 M |
$117.73 M |
| Interest Income |
$17.99 M |
$3.15 M |
$47,000.00 |
$706,000.00 |
$1.40 M |
$822,000.00 |
| Interest Expense |
$5.15 M |
$7.69 M |
$5.81 M |
$3.11 M |
$3.80 M |
$842,000.00 |
| Depreciation &
Amortization |
$4.09 M
|
$5.34 M
|
$7.59 M
|
$8.98 M
|
$9.21 M
|
$6.71 M
|
| EBITDA |
-$38.47 M
|
-$36.45 M
|
-$135.12 M
|
-$75.45 M
|
-$107.71 M
|
-$80.95 M
|
| EBITDA Ratio |
-0.15 |
-0.25 |
-5.09 |
-2.51 |
-4.2 |
-3.42 |
| Operating Income Ratio
|
-0.24
|
-0.28
|
-5.1
|
-2.86
|
-4.61
|
-3.95
|
| Total Other
Income/Expenses Net |
-$14.07 M
|
-$4.54 M
|
-$5.77 M
|
-$1.17 M
|
-$7.87 M
|
$5.92 M
|
| Income Before Tax |
-$60.89 M |
-$44.15 M |
-$140.93 M |
-$87.36 M |
-$126.19 M |
-$88.18 M |
| Income Before Tax Ratio
|
-0.24
|
-0.31
|
-5.31
|
-2.9
|
-4.92
|
-3.73
|
| Income Tax Expense |
-$5.60 M |
-$2.92 M |
-$9.41 M |
-$13.27 M |
-$22.26 M |
-$16.55 M |
| Net Income |
-$55.29 M |
-$41.22 M |
-$131.52 M |
-$74.09 M |
-$103.93 M |
-$71.63 M |
| Net Income Ratio |
-0.22 |
-0.29 |
-4.96 |
-2.46 |
-4.05 |
-3.03 |
| EPS |
-1.13 |
-0.9 |
-3.1 |
-2.33 |
-3.81 |
-2.62 |
| EPS Diluted |
-1.13 |
-0.9 |
-3 |
-2.33 |
-3.81 |
-2.62 |
| Weighted Average Shares
Out |
$48.89 M
|
$45.71 M
|
$42.49 M
|
$31.78 M
|
$27.31 M
|
$27.31 M
|
| Weighted Average Shares
Out Diluted |
$48.89 M
|
$45.71 M
|
$43.86 M
|
$31.78 M
|
$27.31 M
|
$27.31 M
|
| Link |
|
|
|
|
|
|
